SCHEMBL7670145

SCHEMBL7670145

CCCCCC(O)CC/C=C\CCCCCCCC(=O)O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 3/20 0.81
▸ FFAR4 Q5NUL3 3/20 0.81
▸ PPARG P37231 4/20 0.72
▸ PPARD Q03181 4/20 0.72
▸ PPARA Q07869 4/20 0.72
▸ F7 P08709 4/20 0.72
▸ F3 P13726 4/20 0.72
▸ TERT O14746 3/20 0.72
▸ PTPN1 P18031 3/20 0.72
▸ HSD17B10 Q99714 3/20 0.72
▸ FABP4 P15090 3/20 0.72
▸ MAPT P10636 2/20 0.72
▸ BLM P54132 2/20 0.72
▸ LMNA P02545 2/20 0.72
▸ ALOX15 P16050 2/20 0.72
▸ DUSP3 P51452 2/20 0.72
▸ CYP19A1 P11511 2/20 0.72
▸ PTGS1 P23219 2/20 0.72
▸ NR4A2 P43354 2/20 0.72
▸ SIRT6 Q8N6T7 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16680870 1.00 FFAR1 (0.81) FFAR1FFAR4PPARGPPARDPPARA
SCHEMBL16774496 1.00 FFAR1 (0.81) FFAR1FFAR4PPARGPPARDPPARA
SCHEMBL15285528 1.00 FFAR1 (0.81) FFAR1FFAR4PPARGPPARDPPARA
SCHEMBL16680871 1.00 FFAR1 (0.81) FFAR1FFAR4PPARGPPARDPPARA
SCHEMBL18955897 1.00 FFAR1 (0.81) FFAR1FFAR4PPARGPPARDPPARA
SCHEMBL18955898 1.00 FFAR1 (0.81) FFAR1FFAR4PPARGPPARDPPARA
SCHEMBL18258531 1.00 FFAR1 (0.81) FFAR1FFAR4PPARGPPARDPPARA
SCHEMBL18258529 1.00 FFAR1 (0.81) FFAR1FFAR4PPARGPPARDPPARA
SCHEMBL21570587 1.00 FFAR1 (0.81) FFAR1FFAR4PPARGPPARDPPARA
SCHEMBL1567269 1.00 FFAR1 (0.81) FFAR1FFAR4PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111278984-B Homo-polymer of fatty acid hydroxide and method for producing the same 国立大学法人京都大学 2023-09-29 — — CN claimed
CN-116440112-A Anti-inflammatory agent containing rare fatty acid 国立大学法人京都大学 2023-07-18 — — CN claimed
EP-3677686-B1 HYDROXYLATED FATTY ACID MULTIMERS AND PRODUCTION METHOD THEREOF UNIV KYOTO (JP) 2023-06-07 — — EP claimed
US-11130974-B2 Hydroxylated fatty acid homopolymer and production method thereof KYOTO UNIVERSITY (JP) 2021-09-28 — — US claimed
US-20210236448-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2021-08-05 — — US claimed
US-20210079432-A1 HYDROXYLATED FATTY ACID HOMOPOLYMER AND PRODUCTION METHOD THEREOF KYOTO UNIVERSITY (JP) 2021-03-18 — — US claimed
US-20210069141-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2021-03-11 — — US claimed
US-20210071210-A1 Method of Producing 13-Hydroxy-9(Z)-Octadecenoic Acid AJINOMOTO CO., INC. (JP) 2021-03-11 — — US claimed
EP-3778910-A1 METHOD FOR PRODUCING 13-HYDROXY-9(Z)-OCTADECENOIC ACID AJINOMOTO CO., INC. (JP) 2021-02-17 — — EP claimed
EP-3677686-A1 HYDROXYLATED FATTY ACID HOMOPOLYMER AND PRODUCTION METHOD THEREOF Kyoto University (JP) 2020-07-08 — — EP claimed
CN-111278984-A Homopolymers of hydroxylated fatty acids and process for producing the same 国立大学法人京都大学 2020-06-12 — — CN claimed
EP-3097910-B1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID UNIV KYOTO (JP) 2020-05-13 — — EP claimed
US-20200101036-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2020-04-02 — — US claimed
US-20170007564-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2017-01-12 — — US claimed
US-20170000752-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2017-01-05 — — US claimed
EP-3097910-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID Kyoto University (JP) 2016-11-30 — — EP claimed
EP-3097911-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID Kyoto University (JP) 2016-11-30 — — EP claimed
EP-4740753-A1 INTESTINAL REGULATOR Noster Inc. (JP) 2026-05-13 — — EP disclosed
US-6413917-B1 REACTION PRODUCT OF FATTY ACID, SULFUR AND HYDROGEN SULFIDE DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-07-02 — — US disclosed
EP-1116782-A1 EXTREME-PRESSURE ADDITIVE, PROCESS FOR PRODUCING THE SAME, CUTTING FLUID, AND GRINDING FLUID DAINIPPON INK AND CHEMICALS, INC. (JP) 2001-07-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200101036-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID FASN, ELOVL1, FADS1 FFAR1 22/4885FFAR4 36/4885PPARG 149/4885
US-20170007564-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID ELOVL1, FASN, FADS1 FFAR1 22/4885FFAR4 34/4885PPARG 147/4885
US-20210236448-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID FASN, ELOVL1, FADS1 FFAR1 22/4885FFAR4 36/4885PPARG 149/4885
US-20210079432-A1 HYDROXYLATED FATTY ACID HOMOPOLYMER AND PRODUCTION METHOD THEREOF FASN, SCD, SCD5 FFAR1 38/4885FFAR4 31/4885PPARG 773/4885
US-20210069141-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID ELOVL1, ELOVL5, ELOVL3 FFAR1 10/4885FFAR4 14/4885PPARG 54/4885
US-20170000752-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID ELOVL1, ELOVL5, ELOVL3 FFAR1 10/4885FFAR4 14/4885PPARG 54/4885
US-11130974-B2 Hydroxylated fatty acid homopolymer and production method thereof FASN, SCD, SCD5 FFAR1 38/4885FFAR4 31/4885PPARG 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback